XH-02

· Peking Union Medical College Hospital

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XH-02, covering 2026-04-15 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: An Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism [Phase 2]